Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
318.55
+1.62 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
783,641
Open
319.11
Bid (Size)
318.71 (1)
Ask (Size)
318.72 (15)
Prev. Close
316.93
Today's Range
315.60 - 321.45
52wk Range
208.62 - 321.80
Shares Outstanding
44,891,523
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
June 28, 2024
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening...
Via
Talk Markets
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
UroGen Pharma stock had its Relative Strength (RS) Rating upgraded to 91 Thursday, up from 87 a day earlier.
Via
Investor's Business Daily
Performance
YTD
+40.11%
+40.11%
1 Month
+17.79%
+17.79%
3 Month
+39.56%
+39.56%
6 Month
+40.11%
+40.11%
1 Year
+44.30%
+44.30%
More News
Read More
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
June 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 26, 2024
Via
Chartmill
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
Via
Investor's Business Daily
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings)
June 12, 2024
Via
Benzinga
Expert Ratings For United Therapeutics
May 21, 2024
Via
Benzinga
The Latest Analyst Ratings For United Therapeutics
May 02, 2024
Via
Benzinga
The 3 Best Medical Device Stocks to Buy in June 2024
June 20, 2024
Via
InvestorPlace
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
June 19, 2024
Via
Benzinga
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
Via
Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
June 11, 2024
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Halozyme Therapeutics Scores RS Rating Jump To 91
June 07, 2024
Via
Investor's Business Daily
For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals.
June 05, 2024
Via
Chartmill
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
June 04, 2024
Via
InvestorPlace
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
June 03, 2024
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
May 20, 2024
Via
InvestorPlace
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 16, 2024
Via
Investor's Business Daily
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
May 15, 2024
Via
Chartmill
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
May 14, 2024
Via
Investor's Business Daily
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.